<code id='94798A2C55'></code><style id='94798A2C55'></style>
    • <acronym id='94798A2C55'></acronym>
      <center id='94798A2C55'><center id='94798A2C55'><tfoot id='94798A2C55'></tfoot></center><abbr id='94798A2C55'><dir id='94798A2C55'><tfoot id='94798A2C55'></tfoot><noframes id='94798A2C55'>

    • <optgroup id='94798A2C55'><strike id='94798A2C55'><sup id='94798A2C55'></sup></strike><code id='94798A2C55'></code></optgroup>
        1. <b id='94798A2C55'><label id='94798A2C55'><select id='94798A2C55'><dt id='94798A2C55'><span id='94798A2C55'></span></dt></select></label></b><u id='94798A2C55'></u>
          <i id='94798A2C55'><strike id='94798A2C55'><tt id='94798A2C55'><pre id='94798A2C55'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:1868
          Grail

          Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.

          The suits, which were filed earlier this week, are complicated by the fact that Grail was purchased by Illumina, the largest DNA sequencing firm, for $8 billion in 2021 — yet Illumina has left Grail to operate as a separate company. Illumina is named in the suit.

          advertisement

          All three plaintiffs are being represented by the Vora Law Firm, based in Santa Monica, Calif.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Elevance, SCAN deals highlight health insurer acquisition scrutiny
          Elevance, SCAN deals highlight health insurer acquisition scrutiny

          AdobeAdealisneverreallydoneuntilit’sdone.OnTuesday,twodifferentproposedinsuranceplanacquisitionsondi

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Weight loss drugs aren’t covered by Obamacare. That may change

          RHONAWISE/AFPviaGettyImagesWASHINGTON—Drugmakersaredoingeverythingtotapthebottomlesswellofdemandforn